Polymeric nanoparticles based on polylactide and related copolymers

被引:10
作者
Chiellini, E [1 ]
Covolan, VL [1 ]
Orsini, LM [1 ]
Solaro, R [1 ]
机构
[1] Univ Pisa, Dipartimento Chim & Chim Ind, UdR, INSTM Consortium, I-56126 Pisa, Italy
关键词
biocompatible polymers; biodegradable polymers; nanoparticles; polyesters; polylactides;
D O I
10.1002/masy.200350730
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
The preparation of nanoparticle suspensions was carried out by using commercial biodegradable polymers as poly(d,l-lactide), poly(d,l-lactide-co-glycolide) and poly(d,l-lactide-co-epsilon-caprolactone). The method of preparation was based on the controlled addition of polymer organic solution to an aqueous phase containing dispersing agents. Poly(ethylene glycol) (10, 20, and 35 kDa grade), Tween 20, and Pluronic F-127 were used as dispersing agents in the aqueous phase. Content and type of both polymeric matrix and dispersing agent resulted of paramount relevance for the attainment of monodispersed nanoparticles with average diameter of about 130 nm. The addition of a steric stabilizer allowed for nanoparticle purification and isolation while preventing their agglomeration. The best results were obtained by using 35 kDa grade poly(ethylene glycol) as dispersing agent and either mannitol or glycidylisopropylidenglyceryl-beta-cyclodextrin as steric stabilizer. The adopted procedure afforded biodegradable nanoparticle suspensions that could be used for the incapsulation and intravenous administration of biologically active proteins and oligopeptides.
引用
收藏
页码:345 / 354
页数:10
相关论文
共 16 条
[1]  
Bizzarri R., 2001, CHIM IND-MILAN, V83, P51
[2]   Targeted administration of proteic drugs. I. Preparation of polymeric nanoparticles [J].
Chiellini, E ;
Chiellini, EE ;
Chiellini, F ;
Solaro, R .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2001, 16 (06) :441-465
[3]  
CHIELLINI E, 1998, TECHNOMICS, V1, P13
[4]  
CHIELLINI E, 1992, Patent No. 509968
[5]  
CHIELLINI E, 1992, Patent No. [486445, 0486445]
[6]  
Cho KY, 1999, MACROMOL RAPID COMM, V20, P598, DOI 10.1002/(SICI)1521-3927(19991101)20:11<598::AID-MARC598>3.0.CO
[7]  
2-1
[8]  
Cowdall J., 1999, PCT Int. Appl. WO, Patent No. 9902131
[9]  
Cowdall J., 1999, PCT Int. Appl. WO, Patent No. 9902135
[10]  
Kreuter J., 1994, Encyclopedia of Pharmaceutical Technology, p165.190, DOI DOI 10.1002/SMLL.201702037